Evaluation of polyvinyl alcohol cryogel as an acoustic coupling medium for low-intensity transcranial focused ultrasound

2014 ◽  
Vol 24 (4) ◽  
pp. 332-338 ◽  
Author(s):  
Wonhye Lee ◽  
Stephanie D. Lee ◽  
Michael Y. Park ◽  
Jaechun Yang ◽  
Seung-Schik Yoo
2021 ◽  
Author(s):  
Hyeonseok Jeong ◽  
Jooyeon Jamie Im ◽  
Jong-Sik Park ◽  
Seung-Hee Na ◽  
Wonhye Lee ◽  
...  

Author(s):  
Christine Park ◽  
Mengyue Chen ◽  
Taewon Kim

Low-intensity transcranial focused ultrasound (LI-tFUS) stimulation is a non-invasive neuromodulation tool that demonstrates high target localization accuracy and depth penetration. It has been shown to modulate activities in the primary motor and somatosensory cortex. Previous studies in animals and humans acknowledged the possibility of indirect stimulation of the peripheral auditory pathway that could confound the somatosensory and motor responses observed with LI-tFUS stimulation. Here, we discuss the implications and interpretations of auditory confounding in the context of neuromodulation.


2019 ◽  
Vol 46 (12) ◽  
pp. 5444-5453 ◽  
Author(s):  
Steven P. Allen ◽  
Tom Steeves ◽  
Austin Fergusson ◽  
Dave Moore ◽  
Richey M Davis ◽  
...  

2003 ◽  
Vol 29 (9) ◽  
pp. 1351-1358 ◽  
Author(s):  
Adrian F Prokop ◽  
Shahram Vaezy ◽  
Misty L Noble ◽  
Peter J Kaczkowski ◽  
Roy W Martin ◽  
...  

2018 ◽  
Author(s):  
Wynn Legon ◽  
Priya Bansal ◽  
Leo Ai ◽  
Jerel K. Mueller ◽  
Gregg Meekins ◽  
...  

AbstractBackgroundLow intensity transcranial focused ultrasound (tFUS) is a new method of non-invasive neuromodulation that uses acoustic energy to affect neuronal excitability. tFUS offers high spatial resolution and adjustable focal lengths for precise neuromodulation of discrete regions in the human brain. Before the full potential of low intensity ultrasound for research and clinical application can be investigated, data on the safety of this technique is indicated.Objective/HypothesisTo provide an initial evaluation of the safety of tFUS for human neuromodulation through participant report and neurological assessment surrounding pilot investigation of tFUS for neuromodulation.MethodsParticipants (N = 120) that were enrolled in one of seven human ultrasound neuromodulation studies at the University of Minnesota (2015 – 2017) were queried to complete a follow-up Participant Report of Symptoms questionnaire assessing their self-reported experience and tolerance to participation in tFUS research and the perceived relation of symptoms to tFUS.ResultsA total of 64/120 participant (53%) responded to follow-up requests to complete the Participant Report of Symptoms questionnaire. During the conduct of the seven studies in this report, none of the participants experienced serious adverse effects. From the post-hoc assessment of safety using the questionnaire, 7/64 reported mild to moderate symptoms, that were perceived as ‘possibly’ or ‘probably’ related to participation in tFUS experiments. These reports included neck pain, problems with attention, muscle twitches and anxiety. The most common unrelated symptoms included sleepiness and neck pain. There were initial transient reports of mild neck pain, scalp tingling and headache that were extinguished upon follow-up. No new symptoms were reported upon follow up out to 1 month.Conclusions(s)To date, in the literature and including this report, no serious adverse events have been reported as a result of low intensity tFUS for human neuromodulation. Here, we report new data on minor transient events. As currently employed with the parameters used in the studies in this report, tFUS looks to be a safe form of transient neuromodulation in humans.


Sign in / Sign up

Export Citation Format

Share Document